John ApSimon, Executive Director, Canada Research Chairs Program shares a laugh with Provost Tony Masi during the May 22 reception honouring McGill's newest CRC, James McGill and William Dawson recipients.
Owen Egan

Sweet 16: New McGill CRCs announced

by Neale McDevitt McGill University researchers just got a boost in the arm—to the tune of $13.4 million. As was announced on May 23, by Dr. Colin Carrie, Secretary to the Honourable Maxime Bernier, Minister of Industry and minister responsible for the Canada Research Chairs Program, 16 of our researchers are among the 98 newly appointed CRCs. The group is comprised of six Tier-1 and ten Tier-2 Chairs. In addition to the CRC funding, the Canada Foundation for Innovation is investing approximately $2.5 million to fund research infrastructure essential to the work done by 15 of those Chairs. Here is a list of the new CRCs.

Luis B. Agellon — Tier 1. Canada Research Chair in Emerging Roles of Nutrigenomics and Nutrigenetics in the Molecular Regulation of Metabolism in Health and Disease

Shelley Clark — Tier 2. Canada Research Chair in Youth, Gender and Global Health

Kim M. Cornish — Tier 1. Canada Research Chair in Developmental Neuroscience and Education

Florence S. Dzierszinski — Tier 2. Canada Research Chair in Parasite Pathogenesis

Bruno Giros — Tier 1. Canada Research Chair in the Neurobiology of Mental Illness

Pascal Hubert — Tier 2. Canada Research Chair in Advanced Composite Materials

Elizabeth A. V. Jones — Tier 2. Canada Research Chair in Embryonic Biomechanics

Pavlos Kollias — Tier 2. Canada Research Chair in Radar Applications in Weather and Climate Research

Stéphane A. Laporte — Tier 2. Renewal. Canada Research Chair in Molecular Endocrinology

Luc Mongeau — Tier 1. Canada Research Chair in Flow-Induced Sound and Vibrations

Wissam S. Musallam — Tier 2. Canada Research Chair in Neural Prostheses

Tomi Pastinen — Tier 2. Canada Research Chair in Human Genomics

Faiz Jamil Ragep — Tier 1. Canada Research Chair in the History of Science in Islamic Societies

Ralf Schirrmacher — Tier 2. Canada Research Chair in Synthesis of Novel Radiopharmaceuticals for Postitron Emission Tomography in Neurology and Oncology

Amir Shmuel — Tier 2. Canada Research Chair in Neuroscience and Brain Imaging

Michael J.L. Sullivan — Tier 1. Canada Research Chair in Behavioural Health